Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8.37M Buy
80,200
+20,000
+33% +$2.26M 0.6% 41
2017
Q3
$8.78M Buy
60,200
+5,316
+10% +$724K 0.57% 39
2017
Q2
$7.13M Buy
54,884
+4,783
+10% +$586K 0.44% 61
2017
Q1
$6.23M Buy
50,101
+4,731
+10% +$566K 0.34% 78
2016
Q4
$5.25M Sell
45,370
-15,393
-25% -$1.71M 0.36% 69
2016
Q3
$6.35M Sell
60,763
-4,893
-7% -$530K 0.45% 65
2016
Q2
$6.48M Sell
65,656
-3,963
-6% -$410K 0.49% 60
2016
Q1
$6.97M Buy
69,619
+5,028
+8% +$518K 0.44% 68
2015
Q4
$7.74M Buy
+64,591
New +$7.47M 0.46% 56
2014
Q3
Sell
-81,138
Closed -$6.97M 743
2014
Q2
$6.97M Hold
81,138
0.21% 147
2014
Q1
$5.66M Buy
+81,138
New +$6.43M 0.19% 145

Other funds holding CELG

GLG LLC's CELG Position: Q4 2017 in Review

GLG LLC increased its Celgene Corp (CELG) stake by 33% in Q4 2017, buying an estimated $2.26M and bringing the position to 80,200 shares worth $8.37M. The position accounts for 0.6% of the portfolio, ranked #41.

GLG LLC first reported a position in CELG in Q1 2014 and has held it in 11 quarters since. The position peaked at $8.78M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • GLG LLC held 80,200 shares of Celgene Corp worth $8.37M as of Q4 2017.
  • GLG LLC bought 20,000 Celgene Corp shares in Q4 2017, an estimated $2.26M.
  • Celgene Corp made up 0.6% of GLG LLC's portfolio in Q4 2017, its #41 holding.
  • GLG LLC first reported a position in Celgene Corp in Q1 2014 and has held it in 11 quarters since.
  • GLG LLC's Celgene Corp position peaked at $8.78M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.